Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-24 @ 5:28 PM
NCT ID:
NCT03422068
Brief Summary:
The primary objective is to investigate safety and tolerability of BI 1015550 in patients with IPF.
The secondary objectives are to evaluate the pharmacokinetics (PK) of BI 1015550 in patients with IPF.
Study:
NCT03422068
Study Brief:
Protocol Section:
NCT03422068